Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Rare Cannabinoid Company launches Delta-8-THC oil tincture. Delta-8-THC joins apothecary-style line-up of THCV, CBN, CBG, CBC & Rare Hawaiian CBD

Rare Cannabinoid Company announces the launch of its Delta-8-THC oil. This rare cannabinoid joins the brand's apothecary-style line-up of purified THCV, CBN, CBG, CBC, extra high strength 3000mg CBD and Rare Hawaiian CBD. CBDA is also being launched this week.


News provided by

Rare Cannabinoid Company

Mar 09, 2021, 07:45 ET

Share this article

Share toX

Share this article

Share toX

Delta-8-THC joins Rare Cannabinoid Company's apothecary-style line-up of cannabinoids: THCV, CBN, CBG, CBC and Rare Hawaiian CBD.
Delta-8-THC joins Rare Cannabinoid Company's apothecary-style line-up of cannabinoids: THCV, CBN, CBG, CBC and Rare Hawaiian CBD.

HONOLULU, March 9, 2021 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company announces the launch its much-anticipated Delta-8-THC oil tincture. This rare cannabinoid joins the brand's apothecary-style line-up of purified THCV, CBN, CBG, CBC, extra high strength 3000mg CBD and Rare Hawaiian CBD. CBDA is also being launched this week.

"Delta-8-THC offers many of the same health and wellness benefits as Delta-9-THC and may elevate one's mood and mind," says Jared Dalgamouni, founder and CEO of Rare Cannabinoid Company.

“A lot of customers have been asking for Delta-8-THC so we’re very excited to be able to offer this purified oil now."

Post this

Delta-9-THC is the main psychoactive ingredient in cannabis and is only sold in cannabis dispensaries. Delta-8-THC is chemically similar but is derived from hemp and can be sold in stores and online across most of the United States.

"A lot of customers have been asking for Delta-8-THC so we're very excited to be able to offer this purified oil now," Dalgamouni says.

Scientific and anecdotal evidence suggests that Delta-8-THC is about half to two-thirds as intoxicating as Delta-9-THC. It is believed to offer a smooth high without the racing thoughts, anxiety or paranoia that Delta-9-THC can sometimes induce.

"This could make Delta-8-THC a better choice for people who are using it for therapeutic rather than recreational purposes," says Dalgamouni.

Newcomers to cannabis or those who prefer a more functional high may also enjoy it alongside those who are well-accustomed to the intoxicating effects of THC.

Like all cannabinoids, Delta-8-THC interacts with the body's Endocannabinoid System (ECS), offering many potential therapeutic benefits. The National Cancer Institute describes it as having "antiemetic, anxiolytic, appetite-stimulating, analgesic, and neuroprotective properties."

Delta-8-THC has been studied for reducing cancerous tumors in mice and preventing vomiting in child cancer patients undergoing chemotherapy treatment. Other studies have been carried out on Delta-8-THC's potential for improving cognitive function and raising levels of acetylcholine (Ach) in the brain, which is noteworthy because declining levels of Ach are related to Alzheimer's Disease.

Rare Cannabinoid Company's new product contains 500mg Delta-8-THC in a 30ml bottle and sells for just $49, including free U.S. shipping. Customers can also subscribe and save 15% on every order and cancel at any time without penalties. Interested wholesalers with brick-and-mortar stores can enquire here.

The Delta-8-THC tincture is a sublingual oil, which means that it is placed under the tongue, held for 30 seconds and swallowed. This ensures that it enters one's system quickly without smoking or vaping.

More and more people are turning to sublingual tinctures due to the U.S. Mail ban on all vaping devices, liquids and components, which includes Delta-8-THC vape products. (UPS, FedEx and DHL are also banning shipments of vape products, including Delta-8-THC vape items.)

Rare Cannabinoid Company specializes in "rare" or "minor" cannabinoids and was the first in the world to offer a purified THCV oil tincture.

"The idea behind our apothecary-style offering is that people can mix and match cannabinoids according to their specific needs, essentially creating their own unique blend," says Dalgamouni.

After all, each cannabinoid is believed to offer different benefits. THCV may be helpful for appetite suppression, weight loss and energy. CBN is believed to help people relax and improve their sleep. CBG is being studied for uses including pain, inflammation and aging. CBC may boost anandamide – the "bliss" chemical found in the brain – and therefore CBC may be helpful in lifting one's mood. Rare Cannabinoid Company is also launching a CBDA product, which has been studied for easing nausea and among other potential benefits.

Each rare cannabinoid can be purchased as a 500mg sublingual tincture. They can be combined with each other, full spectrum Rare Hawaiian CBD or boosted with extra high strength 3000mg CBD. "Ready blends" are ready-mixed one-to-one rare cannabinoid with full spectrum Rare Hawaiian CBD for a one-and-done oil that offers the entourage effect.

Please note that due to Delta-8-THC's possible intoxicating effects people cannot drive or operate machinery while taking it. It may also cause one to turn up positive on a drug test. It is currently legal in most of the United States but is banned in: Alaska, Arizona, Arkansas, Colorado, Delaware, Idaho, Iowa, Mississippi, Montana, Rhode Island and Utah. This means that it cannot be sold in stores or shipped to addresses in those states.

Rare Cannabinoid Company was established in the first quarter of 2020 by the founders of Hawaiian Choice, Hawaii's most-popular CBD brand. The company was designed to go beyond CBD and THC by offering an apothecary-style approach to cannabinoids so that every customer can design their perfect blend for morning, night or everyday relief.

Media Contact

Jennifer Carlile, Rare Cannabinoid Company, (808)762-1313, [email protected]

Twitter

SOURCE Rare Cannabinoid Company

Modal title

Delta-8-THC is seen alongside some of Rare Cannabinoid Company's other products, including THCV, CBN, CBG, CBC, extra high strength 3000mg CBD and full spectrum Rare Hawaiian CBD.
Delta-8-THC is seen alongside some of Rare Cannabinoid Company's other products, including THCV, CBN, CBG, CBC, extra high strength 3000mg CBD and full spectrum Rare Hawaiian CBD.
Rare Cannabinoid Company's new Delta-8-THC tincture can be taken alone for a smooth high and wellness benefits or combined with THCV, CBN, CBG or CBC to heighten other effects.
Rare Cannabinoid Company's new Delta-8-THC tincture can be taken alone for a smooth high and wellness benefits or combined with THCV, CBN, CBG or CBC to heighten other effects.
Delta-8-THC is seen alongside some of Rare Cannabinoid Company's other products, including THCV, CBN, CBG, CBC, extra high strength 3000mg CBD and full spectrum Rare Hawaiian CBD. Rare Cannabinoid Company's new Delta-8-THC tincture can be taken alone for a smooth high and wellness benefits or combined with THCV, CBN, CBG or CBC to heighten other effects.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.